We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Protalix BioTherapeutics Inc | AMEX:PLX | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.02 | -1.72% | 1.14 | 1.185 | 1.13 | 1.17 | 219,972 | 00:19:41 |
|
|
1.
Names of Reporting Persons.
Camber
Capital Management LLC
42-1693587
|
|
2.
Check the Appropriate Box if a Member of a Group
(a)
☐
(b)
☐
|
|
3. SEC
Use Only
|
|
4.
Citizenship or Place of Organization
Massachusetts
|
|
Number
of Shares
Beneficially
Owned
by
Each
Reporting
Person
With:
|
5. Sole
Voting Power
0
shares
|
6.
Shared Voting Power
1,562,933
shares
|
|
7. Sole
Dispositive Power
0
shares
|
|
8.
Shared Dispositive Power
1,562,933
shares
|
|
9.
Aggregate Amount Beneficially Owned by Each Reporting
Person
Camber Capital Management LLC
– 1,562,933 shares
|
|
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
☐
|
|
11.
Percent of Class Represented by Amount in Row (9)
Camber Capital Management LLC
– 1.54%
|
|
12.
Type of Reporting Person
Camber
Capital Management LLC – 00 (Limited Liability
Company)
|
|
|
1.
Names of Reporting Persons.
Stephen
DuBois
Not
applicable
|
|
2.
Check the Appropriate Box if a Member of a Group
(a)
☐
(b)
☐
|
|
3. SEC
Use Only
|
|
4.
Citizenship or Place of Organization
Stephen
DuBois – United States
|
|
Number
of Shares
Beneficially
Owned
by
Each
Reporting
Person
With:
|
5. Sole
Voting Power
0
shares
|
6.
Shared Voting Power
1,562,933
shares
|
|
7. Sole
Dispositive Power
0
shares
|
|
8.
Shared Dispositive Power
1,562,933
shares
|
|
9.
Aggregate Amount Beneficially Owned by Each Reporting
Person
Stephen
DuBois – 1,562,933 shares
|
|
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
☐
|
|
11.
Percent of Class Represented by Amount in Row (9)
Stephen DuBois
– 1.54%
|
|
12.
Type of Reporting Person
Stephen
DuBois – IN
|
|
|
(a)
|
[_]
|
Broker
or dealer registered under Section 15 of the Act (15
U.S.C. 78o).
|
|
(b)
|
[_]
|
Bank as
defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
[_]
|
Insurance
company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
[_]
|
Investment
company registered under Section 8 of the Investment Company Act of
1940 (15 U.S.C. 80a-8).
|
|
(e)
|
[_]
|
An
investment adviser in accordance
with ss.240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
[_]
|
An
employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
[_]
|
A
parent holding company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
[_]
|
A
savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
[_]
|
A
church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
|
|
(j)
|
[_]
|
Group,
in accordance with ss.240.13d-1(b)(1)(ii)(J).
|
|
|
1 Year Protalix BioTherapeutics Chart |
1 Month Protalix BioTherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions